Tilray Brands, Inc.
TSX:TLRY.TODrug Manufacturers - Specialty & Generic
Healthcare
$3.23 -1.19%
-$0.08 today
- Market cap
- $477.35M
- Beta
- 1.88
- P/E (TTM)
- -0.3
- EPS (TTM)
- -$16.38
52W Low $0.49High $21.57
Volume 0.86M
Average 0.64M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$94.60M
FY 2025 · Annual
Investing Cash Flow
-$46.72M
FY 2025 · Annual
Financing Cash Flow
$133.51M
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY2021 May 2021 | FY2022 May 2022 | FY2023 May 2023 | FY2024 May 2024 | FY2025 May 2025 |
|---|---|---|---|---|---|
| Net Income | (336.01M) | (434.13M) | (1.44B) | (222.4M) | (2.18B) |
| Depreciation & Amortization | 67.83M | 154.59M | 130.15M | 126.91M | 133.49M |
| Deferred Income Tax | (24.87M) | (27.54M) | (31.95M) | (38.87M) | (121.02M) |
| Stock-Based Compensation | 17.35M | 35.99M | 39.6M | 31.77M | 24.29M |
| Change in Working Capital | (50.94M) | (91.77M) | 14.4M | (8.87M) | (62.56M) |
| Accounts Receivables | (23.51M) | (5.84M) | 4.17M | (6.58M) | (17.8M) |
| Inventory | (35.29M) | (45.75M) | (12.93M) | (15.58M) | (13.56M) |
| Accounts Payables | 14.5M | (44.65M) | 20.04M | 0 | 0 |
| Other Working Capital | (6.64M) | 4.47M | 3.14M | (8.87M) | (31.2M) |
| Other Non-Cash Items | 281.92M | 185.59M | 1.3B | 80.56M | 2.11B |
| Operating Cash Flow | (44.72M) | (177.26M) | 7.91M | (30.91M) | (94.6M) |
| Capital Expenditures | (38.87M) | (34.06M) | (20.8M) | (29.25M) | (32.92M) |
| Acquisitions (Net) | 66.61M | 326K | (26.72M) | (52.12M) | (18.11M) |
| Purchases of Investments | 6.61M | 0 | (241.9M) | 0 | 0 |
| Sales of Investments | 8.43M | 0 | 289.42M | 0 | 0 |
| Other Investing Activities | 3.33M | 12.21M | (285.11M) | 209.72M | 4.31M |
| Investing Cash Flow | 46.11M | (21.53M) | (285.11M) | 128.35M | (46.72M) |
| Debt Repayment | 45.51M | (123.55M) | (58.25M) | (83.81M) | (26.14M) |
| Common Stock Issued | 102.55M | 262.51M | 129.59M | 8.62M | 161.19M |
| Common Stock Repurchased | 0 | (8.69M) | (1.19M) | 0 | 0 |
| Dividends Paid | 0 | (7.48M) | 0 | 0 | 0 |
| Other Financing Activities | (23.75M) | 0 | (804.41K) | 0 | (1.54M) |
| Financing Cash Flow | 124.31M | 128.2M | 70.16M | (75.19M) | 133.51M |
| Effect of Forex Changes | 2.12M | (1.96M) | (2.23M) | (549K) | 1.14M |
| Net Change in Cash | 127.82M | (72.56M) | (209.28M) | 21.71M | (6.67M) |
| Free Cash Flow | (83.59M) | (211.33M) | (12.89M) | (60.15M) | (127.52M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$2.2B
+ D&A$133.5M
+ Stock-Based Comp$24.3M
- Deferred Tax-$121.0M
- Working Capital-$62.6M
+ Other Non-Cash$2.1B
= Operating Cash Flow-$94.6M
- Capex-$32.9M
= Free Cash Flow-$127.5M
Analysis
FY2025 free cash flow is -$127.5M. FCF conversion is 5.8% of net income. Operating cash flow was -$94.6M, with capex of -$32.9M. The largest bridge item is Other Non-Cash at $2.1B.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
No filings found.
Does TLRY.TO generate free cash flow?
Tilray Brands, Inc. (TLRY.TO) generated -$127.52M of free cash flow in fiscal 2025.
How much operating cash flow does TLRY.TO produce?
Operating cash flow was -$94.60M, before capital expenditures of $32.92M.
Continue the stock analysis
Jump to another research area for this company.